Tarlatamab Plus Durvalumab As First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial
JOURNAL OF THORACIC ONCOLOGY(2024)
Key words
tarlatamab,extensive-stage small cell lung cancer,phase 3
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined